Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
11:46am, Monday, 20'th May 2024
This new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody drug conjugates from start to finish. It is scheduled to open in 2029.
AstraZeneca lays out plans for $1.5bn Singapore plant
06:55am, Monday, 20'th May 2024
AstraZeneca PLC (LSE:AZN) has unveiled plans to build a US$1.5 billion (£1.2 billion) production plant in Singapore. This will be used to manufacture cancer-killing drugs known as antibody-drug conju
AstraZeneca plans to build $1.5 bln manufacturing facility in Singapore
02:11am, Monday, 20'th May 2024
AstraZeneca is planning to build a $1.5 billion manufacturing facility in Singapore in an effort to enhance its antibody drug conjugates (ADCs) portfolio, the drugmaker said on Monday.
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
12:00am, Monday, 20'th May 2024
AstraZeneca (AZN Quick QuoteAZN - Free Report) announced its plans to spend $1.5 billion to build its first manufacturing facility in Singapore. Once built, it will be the company’s first facility t
WILMINGTON, Del.--(BUSINESS WIRE)--The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blo
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
05:41pm, Friday, 17'th May 2024
AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent rights
7 Blue-Chip Stocks to Protect Your Wealth as the Economy Slows
06:10am, Thursday, 16'th May 2024
For Q1 2024, GDP growth in the United States decelerated to 1.6% from 3.4% in the last quarter. There is no doubt that factors like high interest rates and geopolitical tensions have impacted growth.
AstraZeneca's investigational COVID drug meets primary goals in late-stage study
02:17am, Thursday, 16'th May 2024
AstraZeneca said on Thursday its investigational drug, sipavibart, met primary goals in preventing COVID-19 in immunocompromised patients in a late-stage trial.
Microsoft, Amazon and AstraZeneca invest billions in France
04:01am, Monday, 13'th May 2024
Microsoft Corp (NASDAQ:MSFT) said it will join a string of mega-cap companies in investing billions into the French economy after it pledged fresh investment into the European country. Some €4 billi
Pfizer and AstraZeneca announce new investments of nearly $1 billion in France
08:29am, Sunday, 12'th May 2024
Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
08:20am, Sunday, 12'th May 2024
Johnson & Johnson is a stock that's full of risk these days. Its single-digit growth numbers don't look all that exciting, either.
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
10:46am, Friday, 10'th May 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
10:34am, Thursday, 09'th May 2024
Investors are well aware of the explosive growth potential in weight loss drug stocks. That growth began last year with Eli Lilly (NYSE: LLY ) and Novo Nordisk (NYSE: NVO ).
AstraZeneca starts worldwide withdrawal of COVID vaccine
09:20am, Thursday, 09'th May 2024
AstraZeneca has begun the worldwide withdrawal of its COVID vaccine - ending an era in which it saved millions of lives while being dogged by controversy.
AstraZeneca pulls its COVID-19 vaccine from the European market
09:18pm, Wednesday, 08'th May 2024
LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.
